Form 4: Abbott Laboratories Executive Sells Shares
SEC Form 4 Filing
Eric Shroff, a Senior Vice President at Abbott Laboratories, sold 562 common shares at $138.17 on March 3, 2025.
Summary
- Eric Shroff, a Senior Vice President of Abbott Laboratories, reported a transaction on SEC Form 4.
- On March 3, 2025, Shroff sold 562 common shares of Abbott Laboratories at a price of $138.17 per share.
- Following the transaction, Shroff directly owns 31,970 common shares of Abbott Laboratories.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a share sale by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about a company's prospects, although a single sale doesn't necessarily indicate a negative outlook.
Stakeholder Impact
- The sale of shares by a company executive could be perceived as a neutral to slightly negative signal by shareholders, depending on the context and the size of the transaction.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of transaction: Eric Shroff sold 562 common shares. |
| 03/04/2025 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.